Investing Profile
Michael Aberman
Your Intro Paths to Michael Aberman
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Michael is a member of
The Wharton School Network
818 CONNECTIONS
Morgan Stanley Network
697 CONNECTIONS
Cornell University Network
384 CONNECTIONS
Credit Suisse Network
311 CONNECTIONS
My Perfect Sale (acquired by Sugar, Inc) Network
131 CONNECTIONS
Find Michael Aberman on
cbCurrent Investing Position
Regeneron Ventures General Partner
Investment Range
$100K - $2.0M
Sweet Spot
$1M
Investments On Record
1
Michael Aberman is on these Sector & Stage Rankings
Michael Aberman's Investments On Record (1)
| Company | StageDateRound Size | Total Raised |
|---|---|---|
Tasca | Series ADec 2024$48M | $48M |
Michael Aberman's Experience
Resident NewYork-Presbyterian HospitalPresent
Senior Director, Business Development AntigenicsPresent
Biotech Analyst Morgan StanleyPresent
Biotech Analyst Credit SuissePresent
Senior Vice President, Strategy and Investor Relations RegeneronPresent
Board Member Rover DiagnosticsPresent
SeniorAdvisor ImmunaiPresent
Board Member Unnatural Products Inc.Present
Board Member Unnatural ProductsPresent
Business Advisor Excision BioTherapeuticsPresent
Board Member My Perfect Sale (acquired by Sugar, Inc)Present
Board Member XenImmune Therapeutics, Inc.Present
President and CEO My Perfect Sale (acquired by Sugar, Inc)Present
President and CEO Quentis Therapeutics, IncPresent
General Partner My Perfect Sale (acquired by Sugar, Inc)Present
General Partner Regeneron VenturesPresent
Michael Aberman's Education
Cornell University BA Biology
University of Toronto MD Medicine
The Wharton School MBA Healthcare
Investors who invest with Michael Aberman
Sign in with Google →Scouts & Angels Affiliated With Michael Aberman
Sign in with Google →